MedPath

IMPACT OF EDUCATION ON THE KAP TOWARDS ADVERSE DRUG REACTION REPORTING AMONG PHARMACY STUDENTS

Not Applicable
Registration Number
CTRI/2021/09/036671
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL THE STUDENTS PURSUING BACHELOR OF PHARMACY AND DOCTOR OF PHARMACY PROGRAMMES AT NGSMINSTITUTEOF PHARMACEUTICAL SCIENCES DURING THE STUDYT PERIOD

Exclusion Criteria

Students who are not willing to give their consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THE STUDY IS EXPECTED TO ASSESS THE BASELINE SCORE OF KAP TOWARDS ADVERSE DRUG REACTION REPORTING AMONG PHARMACY STUDENTSTimepoint: 8 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
IT IS ALSO EXPECTED TO IMPROVE THE EXISTING LEVEL OF KAP AFTER EDUCATING THEM ON REPORTING OF ADVERSE DRUG REACTIONS. THEREFORE THE POSITIVE IMPACT ON THE LEVEL OF KAP STUDY OF THE PHARMACY STUDENTS WILL BE ASSESSED BASED ON THE SCORES OBTAINED FROM THE STUDY.Timepoint: 8 months
© Copyright 2025. All Rights Reserved by MedPath